SQM Stock Analysis: Sociedad Quimica y Minera | NYSE
Specialty Chemicals | NYSE, USA | Market Cap: 18.429m USD | 12M Return: 56.3% | US8336351056 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 64.7M
Qual. Beats: 1
Rev. Trend: -52.5%
Qual. Beats: 2
Warnings
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Sociedad Química y Minera de Chile S.A. (SQM) is a Chilean mining and specialty chemicals company that produces and sells specialty plant nutrients, iodine and its derivatives, lithium products, and industrial chemicals to customers across Chile, Latin America, the Caribbean, Europe, North America, and Asia. Its specialty fertilizer portfolio is marketed under brands such as Ultrasol, Qrop, Speedfol, Allganic, Ultrasoline, Prop, and Prohydric, and is positioned toward higher-value crop nutrition uses rather than commodity fertilizer markets.
SQM is one of the worlds largest producers of lithium from brine resources and a leading global supplier of iodine, with both primarily extracted from operations in northern Chile. Its lithium carbonate and lithium hydroxide are key inputs for cathode materials used in lithium-ion batteries, while its iodine derivatives serve medical and pharmaceutical uses (including x-ray contrast media), electronics (polarizing films for LCD and LED screens), biocides, and human and animal nutrition, including iodized salt for iodine deficiency prevention.
Beyond fertilizers and lithium, the company produces potassium sulfate and potassium chloride for crop nutrition, as well as industrial chemicals such as sodium nitrate, potassium nitrate, and solar salts used in glass manufacturing, metal processing, pyrotechnics, and thermal energy storage in concentrated solar power plants. Founded in 1926 and headquartered in Santiago, SQM trades on the NYSE as an ADR and is classified within the Materials sector under the Fertilizers & Agricultural Chemicals sub-industry.
- Lithium prices slump on weak EV demand and oversupply
- Chile lithium royalty tax hikes pressure profit margins
- Iodine and specialty fertilizer sales drive diversified revenue growth
| Net Income: 1.39b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.12 > 0.02 and ΔFCF/TA 12.38 > 1.0 |
| NWC/Revenue: 69.75% < 20% (prev 85.26%; Δ -15.51% < -1%) |
| CFO/TA 0.17 > 3% & CFO 2.75b > Net Income 1.39b |
| Net Debt (1.06b) to EBITDA (2.97b): 0.36 < 3 |
| Current Ratio: 2.61 > 1.5 & < 3 |
| Outstanding Shares: last quarter (285.6m) vs 12m ago 0.01% < -2% |
| Gross Margin: 42.16% > 18% (prev 26.78%; Δ 15.38% > 0.5%) |
| Asset Turnover: 47.95% > 50% (prev 36.71%; Δ 11.24% > 0%) |
| Interest Coverage Ratio: 13.23 > 6 (EBIT TTM 2.64b / Interest Expense TTM 199.5m) |
| A: 0.28 (Total Current Assets 7.63b - Total Current Liabilities 2.93b) / Total Assets 16.6b |
| B: 0.28 (Retained Earnings 4.61b / Total Assets 16.6b) |
| C: 0.19 (EBIT TTM 2.64b / Avg Total Assets 14.1b) |
| D: 0.79 (Book Value of Equity 6.29b / Total Liabilities 7.94b) |
| Altman-Z'' = 4.86 = AA |
| DSRI: 0.64 (Receivables 1.29b/1.27b, Revenue 6.74b/4.23b) |
| GMI: 0.64 (GM 26.78% / 42.16%) |
| AQI: 2.08 (AQ_t 0.23 / AQ_t-1 0.11) |
| SGI: 1.59 (Revenue 6.74b / 4.23b) |
| TATA: -0.08 (NI 1.39b - CFO 2.75b) / TA 16.6b) |
| Beneish M = -2.60 (Cap -4..+1) = A |
As of October 07, 2026, the stock is trading at USD 66.17 with a total of 538,700 shares traded. Over the past week, the price has changed by +0.14%, over one month by -12.54%, over three months by -8.87% and over the past year by +56.32%.
Current recommended Stop Loss: 63.20 (which is 4.5% or 1.3 ATR below the current price).
Sociedad Quimica y Minera has received a consensus analysts rating of 3.83. Therefore, it is recommended to buy SQM.
- StrongBuy: 6
- Buy: 4
- Hold: 7
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 84.8 | 28.1% |
P/E Trailing = 13.2757
P/E Forward = 10.9529
P/S = 2.7402
P/B = 3.1265
P/EG = 0.3182
Revenue TTM = 6.74b USD
EBIT TTM = 2.64b USD
EBITDA TTM = 2.97b USD
Long Term Debt = 4.79b USD (from longTermDebt, last quarter)
Short Term Debt = 455.1m USD (from shortTermDebt, last quarter)
Debt = 5.39b USD (from shortLongTermDebtTotal, last quarter) + Leases 97.9m
Net Debt = 1.06b USD (calculated: Debt 5.39b - CCE 4.33b)
Enterprise Value = 19.5b USD (18.4b + Debt 5.39b - CCE 4.33b)
Interest Coverage Ratio = 13.23 (Ebit TTM 2.64b / Interest Expense TTM 199.5m)
EV/FCF = 10.02x (Enterprise Value 19.5b / FCF TTM 1.94b)
FCF Yield = 9.98% (FCF TTM 1.94b / Enterprise Value 19.5b)
FCF Margin = 28.87% (FCF TTM 1.94b / Revenue TTM 6.74b)
Net Margin = 20.61% (Net Income TTM 1.39b / Revenue TTM 6.74b)
Gross Margin = 42.16% ((Revenue TTM 6.74b - Cost of Revenue TTM 3.90b) / Revenue TTM)
Gross Margin QoQ = 51.06% (prev 44.23%)
Tobins Q-Ratio = 1.18 (Enterprise Value 19.5b / Total Assets 16.6b)
Interest Expense / Debt = 3.70% (Interest Expense 199.5m / Debt 5.39b)
Taxrate = 37.65% (928.4m / 2.47b)
NOPAT = 1.65b (EBIT 2.64b * (1 - 37.65%))
Current Ratio = 2.61 (Total Current Assets 7.63b / Total Current Liabilities 2.93b)
Debt / Equity = 0.86 (Debt 5.39b / totalStockholderEquity, last quarter 6.29b)
Debt / EBITDA = 0.36 (Net Debt 1.06b / EBITDA 2.97b)
Debt / FCF = 0.54 (Net Debt 1.06b / FCF TTM 1.94b)
Total Stockholder Equity = 5.83b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.88% (Net Income 1.39b / Total Assets 16.6b)
RoE = 23.82% (Net Income TTM 1.39b / Total Stockholder Equity 5.83b)
RoCE = 24.85% (EBIT 2.64b / Capital Employed (Equity 5.83b + L.T.Debt 4.79b))
RoIC = 11.95% (NOPAT 1.65b / Invested Capital 13.8b)
WACC = 7.81% (E(18.4b)/V(23.8b) * Re(9.42%) + D(5.39b)/V(23.8b) * Rd(3.70%) * (1-Tc(0.38)))
Discount Rate = 9.42% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -41.82 | Cagr: 0.0%
[DCF] Terminal Value 75.44% ; FCFF base≈1.94b ; Y1≈1.95b ; Y5≈2.07b
[DCF] Fair Price = 217.9 (EV 32.2b - Net Debt 1.06b = Equity 31.1b / Shares 142.8m; r=8.35% [WACC [floored]]; 5y FCF grow 0.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 3.55 | # QB: 1
Revenue Correlation: -52.45 | Revenue CAGR: -13.54% | SUE: 4.0 | # QB: 2
EPS current Quarter (2026-09-30): EPS=2.14 | Chg30d=-2.73% | Revisions=-29% | Analysts=4
EPS current Year (2026-12-31): EPS=7.52 | Chg30d=+1.10% | Revisions=-10% | GrowthEPS=+265.1% | GrowthRev=+76.5%
EPS next Year (2027-12-31): EPS=7.02 | Chg30d=+4.51% | Revisions=+29% | GrowthEPS=-6.6% | GrowthRev=-1.3%
[Analyst] Revisions Ratio: -6% (up=7, down=8)